---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000064"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:31:17.484427+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salarius gets Nasdaq extension to regain listing compliance; milestones set for July/August 2025

## Summary
- Nasdaq Hearings Panel granted extension to comply with Minimum Bid Price and Equity Standards.
- Must regain compliance with Equity Standard (minimum $2.5M stockholders' equity) by early July 2025.
- Must regain compliance with Minimum Bid Price (closing bid $1.00) by early August 2025.
- Previously received delisting notices for non-compliance with both rules; hearing held June 3, 2025.
- Failure to meet milestones may result in revocation of extension and delisting.

## SEC filing metadata
- accession: 0001615219-25-000064
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000064/0001615219-25-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000064/flks-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000064
- JSON: https://secwatch.observer/filing/0001615219-25-000064.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.